[3H]CFT binding assay

JZ Juan Zhen
MR Maarten E. A. Reith
request Request a Protocol
ask Ask a question
Favorite

Prior to [3H]CFT binding assay, LLC-PK1 cells stably transfected with hDAT-WT were treated with various concentrations (1 µM, 3 µM, 10 µM, 30 µM, 50 µM and 100 µM) of crosslinking agent CuP diluted in PBS for 5 minutes at 21°C, as indicated in text. N-ethylamine was not used here to quench residual CuP because it greatly affected the following [3H]CFT binding assay (data now shown). Crosslinker CuP was then thoroughly washed off and cells were dislodged from cell-culture plates by trypsinization. Saturation analysis of [3H]CFT ((2β-carbomethoxy-3β-[4-fluorophenyl]-tropane, 85.9 Ci/mmole, Perkin Elmer, Boston, MA, USA) binding to intact cells in suspension was measured in 96-well plates with sodium phosphate buffer in triplicate as described in our previous work (Liang et al. 2009;Schmitt and Reith 2011). Increasing concentrations of non-radioactive CFT were included in the assay mixture to generate final CFT concentrations of 1,3,10, 30, 100 or 300 nM. Nonspecific binding was defined with 1 μM CFT. Biorad-DC protein kit was used to determine the cellular protein level.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A